← Eichor
Condition: Immunotherapy Toxicity Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunotherapy Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibi
Phase N/A · 6 location(s) · Shantou University Medical College · NCT07357636Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therap
NA · 1 location(s) · The Cooper Health System · NCT06688422Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06589089MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Phase 1/Phase 2 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06712875Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05878964Food Intervention to Reduce Immunotherapy ToXicity
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT05832606Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06461780IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Phase N/A · 6 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07138222Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
NA · 3 location(s) · Institut Claudius Regaud · NCT03514368Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT04615988Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
EARLY_Phase 1 · 6 location(s) · New York Medical College · NCT03719105Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06041477Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT03406247Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07169487Impact of Gonadotoxic Therapies on Fertility
Phase N/A · 1 location(s) · Michael von Wolff · NCT05885048Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Phase N/A · 2 location(s) · University Hospital, Montpellier · NCT06627595Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
NA · 1 location(s) · Erasmus Medical Center · NCT05652673Decoupling Immunotherapy Toxicity and Cancer Response
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07382752
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.